2-[7-hydroxy-8-(hydroxymethyl)-4a,8-dimethyl-2-(thiophen-3-yl)-4H,4aH,5H,6H,7H,8H,8aH,9H-naphtho[2,3-d][1,3]thiazol-4-yl]-N-[2-(morpholin-4-yl)ethyl]acetamide



Compound IDCDAMM00208
Common name2-[7-hydroxy-8-(hydroxymethyl)-4a,8-dimethyl-2-(thiophen-3-yl)-4H,4aH,5H,6H,7H,8H,8aH,9H-naphtho[2,3-d][1,3]thiazol-4-yl]-N-[2-(morpholin-4-yl)ethyl]acetamide
IUPAC name2-[7-hydroxy-8-(hydroxymethyl)-4a,8-dimethyl-2-thiophen-3-yl-4,5,6,7,8a,9-hexahydrobenzo[f][1,3]benzothiazol-4-yl]-N-(2-morpholin-4-ylethyl)acetamide
Molecular formulaC26H37N3O4S2

Experimental data

Retention time44.54
Adduct[M+H]+
Actual mz520.229
Theoretical mz520.23
Error0.96
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.4335

Identifiers and class information

Inchi keyLKMILIKJICSUGF-UHFFFAOYSA-N
SmilesCC12CCC(C(C1CC3=C(C2CC(=O)NCCN4CCOCC4)N=C(S3)C5=CSC=C5)(C)CO)O
SuperclassOrganoheterocyclic compounds
ClassNaphthothiazoles

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)1
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)519.716
Computed dipole moment(dipole)6.209
Total solvent accessible surface area (SASA)804.675
Hydrophobic component of SASA (FOSA)487.594
Hydrophilic component of SASA (FISA)100.536
Pie component of the SASA (PISA)123.657
Weakly polar component of the SASA (WPSA)92.888
Total solvent accesible volume (volume)1527.26
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)11.1
Free energy of solvation of dipole (dip^2/V)0.0252407
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0238926
Globularity descriptor (glob)0.797052
Predicted polarizability in cubic angstroms (QPpolrz)51.011
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.346
Predicted octanol/gas partition coefficient (QPlogPoct)27.741
Predicted water/gas partition coefficient (QPlogPw)18.169
Predicted octanol/water partition coefficient (QPlogPo/w)2.664
Predicted aqueous solubility (QPlogS)-4.097
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.223
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.757
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)194.798
Predicted brain/blood partition coefficient (QPlogBB)-0.347
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)437.667
Predicted skin permeability, log Kp (QPlogKp)-4.231
PM3 calculated ionization potential (IP(ev))8.946
PM3 calculated electron affinity (EA(eV))0.991
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)-0.097
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)70.566
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)18.823
Van der Waals surface area (PSA)99.041
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9NR96TLR9Toll-like receptor (TLR7/TLR9)T11451SEA
O60760HPGDSHematopoietic prostaglandin D synthaseT19433SEA
P21452TACR2Neurokinin 2 receptorT52790SEA
P51679CCR4C-C chemokine receptor type 4T06955SEA
P47901AVPR1BVasopressin V1b receptorT59881SEA
O95602POLR1ADNA-directed RNA polymerase I subunit RPA1T89530SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T11451DI0095Colorectal cancer[ICD-11: 2B91]Q9NR96TLR9
T11451DI0179Hepatitis virus infection[ICD-11: 1E50-1E51]Q9NR96TLR9
T11451DI0252Melanoma[ICD-11: 2C30]Q9NR96TLR9
T11451DI0346Prostate cancer[ICD-11: 2C82]Q9NR96TLR9
T19433DI0148Flatworm infection[ICD-11: 1F70-1F86]O60760HPGDS
T52790DI0218Irritable bowel syndrome[ICD-11: DD91]P21452TACR2
T06955DI0283Mycosis fungoides[ICD-11: 2B01]P51679CCR4
T06955DI0379Sezary syndrome[ICD-11: 2B02]P51679CCR4
T59881DI0009Acute diabete complication[ICD-11: 5A2Y]P47901AVPR1B
T59881DI0041Autism spectrum disorder[ICD-11: 6A02]P47901AVPR1B
T59881DI0194Hypo-osmolality/hyponatraemia[ICD-11: 5C72]P47901AVPR1B

Copyright © 2025